News|Ultrasound Imaging| October 28, 2020

Northwestern Memorial Hospital first in U.S. to adopt Caption AI in emergency department, ICU and cardio-oncology clinic

西北纪念医院的一位超声医师使用Caption Health AI优化超声成像。

西北纪念医院的一位超声医师使用Caption Health AI优化超声成像。


October 28, 2020 — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Health’s artificial intelligence (AI) technology for ultrasound, Caption AI. The FDA cleared, AI-guided ultrasound system enables healthcare providers to acquire and interpret quality ultrasound images of the heart, increasing access to timely and accurate cardiac assessments at the point of care.

Performing an ultrasound exam is a complex skill that takes years to master. Caption AI enables clinicians — including those without prior ultrasound experience — to quickly and accurately perform diagnostic-quality ultrasound exams by providing expert turn-by-turn guidance, automated quality assessment and intelligent interpretation capabilities. The systems are currently in the hospital’s emergency department, medical intensive care unit, cardio-oncology clinic and in use by the hospital medicine group.

"Through our partnership with Caption Health, we are looking to democratize the echocardiogram, a stalwart tool in the diagnosis and treatment of heart disease,” saidPatrick McCarthy, M.D.,chief of cardiac surgery and executive director of theNorthwestern Medicine Bluhm Cardiovascular Institute该团队参与了这项技术的早期开发。“我们的最终目标是在任何我们需要的地方改善心血管健康,而Caption AI正在增加整个医院获得高质量诊断图像的机会。”

“人工智能”通过实时指导如何定位和操作患者身体上的换能器或超声棒,来模拟超声医生的专业知识。该软件向临床医生实时显示他们距离获得高质量超声图像的距离,并在图像达到诊断质量阈值时自动记录图像。人工智能还能自动计算射血分数,即心脏收缩时流出血液的百分比,这是评估心脏功能最广泛使用的指标。

“Northwestern Medicine has been a tremendous partner in helping us develop and validate Caption AI. We are thrilled that they are bringing Caption AI into key clinical settings as our first customer,” said Charles Cadieu, chief executive officer and co-founder of Caption Health. “The clinical, economic and operational advantages of using AI-guided ultrasound are clear. Most important, this solution increases access to a safe and effective diagnostic tool that can be life-saving for patients.”

Point-of-care ultrasound (POCUS)has a number of benefits. Increased usage of POCUS contributes to more timely and accurate diagnoses, more accurate monitoring and has been shown to lead to changes in patient management in 47% of cases for critically ill patients.[1] POCUS also allows patients to avoid additional visits to receive imaging, as well as providing real-time results that can be recorded into a patient’s electronic medical record.

"I think the most exciting part is that Caption AI allows our intensive care unit (ICU) providers to do a point-of-care, real-time ultrasound for a sick patient,” saidJames “Mac” Walter, M.D., associate program director for the pulmonary and critical care medicine fellowship at Northwestern Medicine, who first used the technology on COVID-19 patients in Northwestern Memorial’s ICU. “It’s a way to integrate two worlds — real-time point-of-care ultrasounds and urgent care in the ICU — with details that are ready for cardiologists when they need them.”

The Bluhm Cardiovascular Institute committed to investigating the role of AI and machine learning in the diagnosis and treatment of cardiovascular disease in 2018. Its Clinical Trials Unit was one of Caption Health’s first partners, investigating the effectiveness of Caption Guidance in a clinical trial based, in part, out of Northwestern Memorial Hospital that served as the basis for the software’s landmark FDA authorization earlier this year.

In addition to being used to diagnose and treat patients, Caption AI will be used by fellows who typically need months of practice to learn accurate echocardiography techniques in real time.

Video demo of how the AI technology worksto optimize ultrasound imaging.

For more information:captionhealth.com,feinberg.northwestern.edu/sites/bcvi-ctu

Reference:

1. David P Hall, Helen Jordan, Shirjel Alam, et al. The impact of focused echocardiography using the Focused Intensive Care Echo protocol on the management of critically ill patients, and comparison with full echocardiographic studies by BSE-accredited sonographers. Journal of the Intensive Care Society. First Published March 28, 2017. https://doi.org/10.1177/1751143717700911.

Related Content

The SpeedBird and Concorde device platforms are based on TransMed7’s patented Zero5 work element composed of a fused, single element constructed from 3 hypotubes, laser cut and welded to form articulable twin cutter blades at the end of a rotating open tube
News|Ultrasound Imaging

August 10, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

TimeAugust 10, 2022
arrow
Mindray solidifies its position as an industry innovator and leader in the POCUS market with the debut of the newest edition to the TE Series Ultrasound Family, the TE X
News|Point-of-Care Ultrasound (POCUS)

August 10, 2022 — Mindray North America, a global leader and developer of healthcare technologies and solutions for ...

TimeAugust 10, 2022
arrow
Portable digital radiography brought to remote locations in Nepal
Feature|Radiology Business| By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

TimeAugust 01, 2022
arrow
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology
News|RSNA

July 29, 2022 — The Radiological Society of North America (RSNA), in collaboration with the American Society of ...

TimeJuly 29, 2022
arrow
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology
News|Mobile C-Arms

July 29, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ...

TimeJuly 29, 2022
arrow
Viz.ai, a leading AI-powered disease detection and intelligent care coordination platform, announced it is partnering with Hyperfine, Inc., creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop.
News|Magnetic Resonance Imaging (MRI)

July 27, 2022 — Viz.ai, a leading AI-powered disease detection and intelligent care coordination platform, announced it ...

TimeJuly 27, 2022
arrow
Aidoc artificial intelligence
News|Artificial Intelligence

July 26, 2022 — Aidoc, a leading provider of AI healthcare solutions, today announced a partnership with UofL Health, a ...

TimeJuly 26, 2022
arrow
The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information system market is expected to grow from $2.59 billion in 2022 to $5.48 billion by 2032
News|Oncology Information Management Systems (OIMS)

July 26, 2022 — The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information ...

TimeJuly 26, 2022
arrow
According to ARRS’ American Journal of Roentgenology (AJR), an AI tool for detection of incidental pulmonary embolus (iPE) on conventional contrast-enhanced chest CT examinations had high NPV and moderate PPV, even finding some iPEs missed by radiologists
News|Computed Tomography (CT)

July 21, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), an AI tool for detection of incidental ...

TimeJuly 22, 2022
arrow
3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging Excellence Advisory Services to support radiology departments in hospital and outpatient settings nationwide
News|AHRA

July 18, 2022 — 3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging ...

TimeJuly 19, 2022
arrow
Subscribe Now